Haberer Registered Investment Advisor’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$406K Sell
2,539
-2,369
-48% -$373K 0.25% 61
2014
Q4
$782K Buy
4,908
+533
+12% +$83.1K 0.45% 52
2014
Q3
$615K Sell
4,375
-100
-2% -$13.1K 0.29% 64
2014
Q2
$530K Sell
4,475
-200
-4% -$23.2K 0.24% 66
2014
Q1
$577K Sell
4,675
-400
-8% -$48.5K 0.28% 60
2013
Q4
$579K Sell
5,075
-600
-11% -$68.3K 0.24% 63
2013
Q3
$635K Sell
5,675
-1,600
-22% -$173K 0.23% 64
2013
Q2
$718K Buy
+7,275
New +$755K 0.2% 70

Other funds holding AMGN

Haberer Registered Investment Advisor's AMGN Position: Q1 2015 in Review

Haberer Registered Investment Advisor reduced its Amgen (AMGN) stake by 48% in Q1 2015, selling an estimated $373K and leaving 2,539 shares worth $406K. The position accounts for 0.25% of the portfolio, ranked #61.

Haberer Registered Investment Advisor first reported a position in AMGN in Q2 2013 and has held it in 8 quarters since. The position peaked at $782K in Q4 2014. 1,344 funds tracked by Wall St. Rank hold AMGN as of Q1 2015.

  • Haberer Registered Investment Advisor held 2,539 shares of Amgen worth $406K as of Q1 2015.
  • Haberer Registered Investment Advisor sold 2,369 Amgen shares in Q1 2015, an estimated $373K.
  • Amgen made up 0.25% of Haberer Registered Investment Advisor's portfolio in Q1 2015, its #61 holding.
  • Haberer Registered Investment Advisor first reported a position in Amgen in Q2 2013 and has held it in 8 quarters since.
  • Haberer Registered Investment Advisor's Amgen position peaked at $782K in Q4 2014.
  • 1,344 funds tracked by Wall St. Rank held Amgen as of Q1 2015.

Based on Haberer Registered Investment Advisor's 13F filing for Q1 2015, filed 8 Apr 2015.